Epidemiology of diet, metabolism and non-alcoholic fatty liver disease in Hispanic/Latino adults
- Institution
- ALBERT EINSTEIN COLLEGE OF MEDICINE, NY
- Principal investigator
- Robert C Kaplan
- Funding
- $695K
- Duration
- 2023–2026
Moonbase score
Still being scored
Abstract
Abstract Nonalcoholic fatty liver disease (NAFLD) belongs to a cluster of metabolic conditions that disproportionately affects Latinos, the largest US minority group. Known NAFLD risk factors, like obesity, diabetes, poor diet, and genetic risk alleles, are more common in Latino populations, but we don’t fully understand how these factors contribute to Latinos’ high risks of developing NAFLD and its sequelae of non-alcoholic steatohepatitis (NASH), cirrhosis, and liver cancer. Moreover, prior study designs have been largely limited to case-control comparisons focused on clinically recognized disease. This represents only the “tip of the iceberg,” ignoring the large group with subclinical liver disease due to their abundance of risk factors. This proposal will examine host and bacteria produced metabolic products of diet in a large study sample of Latinos (Hispanic Community Health Study – Study of Latinos, N=16,415 adults from four US centers) with state-of-the-art imaging of subclinical liver fibrosis and steatosis. Based upon our results, diet and metabolome features that predict NAFLD may be translated into low-cost risk screening tests. By improving understanding of specific mechanisms, the study may also help to design interventions to prevent NAFLD, by diet modifications or pharmacologic or non-pharmacologic interventions.
Research team
- Robert D BurkPI
- Robert C KaplanPI
- Jorge R KizerPI
- Jennifer Cohen PricePI
LOADING MOONBASE SCORE
Questions for ALBERT EINSTEIN COLLEGE OF MEDICINE
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Northern California Institute/Res/EduNot yet scored
Stimulant and Polysubstance use, Inflammation and Sex Effects on Myocardial Disease in HIV (SPISE)
Bradley E Aouizerat · $2.0M · 2025–2030
- NIH · Albert Einstein College of MedicineNot yet scored
Multi-omic signatures of gut dysbiosis and cardiovascular comorbidities associated with HIV infection
Robert D Burk · $706K · 2023–2027
- NIH · University of California, San FranciscoNot yet scored
SF Bay Area MACS/WIHS Combined Cohort Study
Bradley E Aouizerat · $4.4M · 2019–2026